Aspen Aerogels, Inc. $ASPN Shares Acquired by Needham Investment Management LLC

Needham Investment Management LLC grew its position in Aspen Aerogels, Inc. (NYSE:ASPN) by 26.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 4,351,700 shares of the construction company’s stock after acquiring an additional 912,000 shares during the period. Needham Investment Management LLC owned approximately 0.05% of Aspen Aerogels worth $12,315,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Verition Fund Management LLC grew its stake in Aspen Aerogels by 47.0% during the 4th quarter. Verition Fund Management LLC now owns 96,973 shares of the construction company’s stock worth $274,000 after purchasing an additional 31,011 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Aspen Aerogels during the 4th quarter worth $445,000. Marshall Wace LLP grew its stake in Aspen Aerogels by 77.5% during the 4th quarter. Marshall Wace LLP now owns 554,180 shares of the construction company’s stock worth $1,568,000 after purchasing an additional 241,990 shares in the last quarter. Samjo Management LLC grew its stake in Aspen Aerogels by 134.3% during the 4th quarter. Samjo Management LLC now owns 798,525 shares of the construction company’s stock worth $2,260,000 after purchasing an additional 457,700 shares in the last quarter. Finally, FirstWave Capital Management LLC acquired a new position in Aspen Aerogels during the 4th quarter worth $1,053,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. TD Cowen lowered their target price on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Weiss Ratings reissued a “sell (d-)” rating on shares of Aspen Aerogels in a research note on Friday, March 27th. Roth Mkm reissued a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a research note on Friday, May 8th. Barclays boosted their target price on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a research note on Monday, May 11th. Finally, Wall Street Zen raised Aspen Aerogels from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Three investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.19.

Aspen Aerogels Trading Up 1.9%

NYSE:ASPN opened at $6.03 on Tuesday. The stock has a 50-day simple moving average of $4.76 and a 200-day simple moving average of $3.82. The stock has a market cap of $500.10 million, a P/E ratio of -4.44 and a beta of 3.02. Aspen Aerogels, Inc. has a 1 year low of $2.30 and a 1 year high of $9.78. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.54 and a current ratio of 2.89.

Aspen Aerogels (NYSE:ASPN) last released its quarterly earnings data on Thursday, May 7th. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). The business had revenue of $37.88 million for the quarter, compared to analyst estimates of $36.58 million. Aspen Aerogels had a negative return on equity of 22.16% and a negative net margin of 48.64%.The company’s revenue was down 51.8% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.06) earnings per share. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. As a group, analysts anticipate that Aspen Aerogels, Inc. will post -0.8 earnings per share for the current fiscal year.

Aspen Aerogels Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.